619 related articles for article (PubMed ID: 17163190)
21. Influenza. More than mom and chicken soup.
Bergen GA; Gompf SG; Sakalosky PA; Sinnott JT
J Fla Med Assoc; 1996 Jan; 83(1):19-22. PubMed ID: 8849975
[TBL] [Abstract][Full Text] [Related]
22. Influenza A virus-induced apoptosis is a multifactorial process: exploiting reverse genetics to elucidate the role of influenza A virus proteins in virus-induced apoptosis.
Morris SJ; Nightingale K; Smith H; Sweet C
Virology; 2005 May; 335(2):198-211. PubMed ID: 15840519
[TBL] [Abstract][Full Text] [Related]
23. [Influenza diagnostics in patient with leukemia suspicion].
Brydak LB; Gawryluk D; Lietzau G; Wiatr E; Machała M
Pol Merkur Lekarski; 2006 Mar; 20(117):341-4. PubMed ID: 16780271
[TBL] [Abstract][Full Text] [Related]
24. [Immunological problems of influenza virus infections].
Schmidt J; Süss J; Stelzner A
Arch Exp Veterinarmed; 1978; 32(3):377-90. PubMed ID: 81042
[TBL] [Abstract][Full Text] [Related]
25. Non-hydrolyzed in digestive tract and blood natural L-carnosine peptide ("bioactivated Jewish penicillin") as a panacea of tomorrow for various flu ailments: signaling activity attenuating nitric oxide (NO) production, cytostasis, and NO-dependent inhibition of influenza virus replication in macrophages in the human body infected with the virulent swine influenza A (H1N1) virus.
Babizhayev MA; Deyev AI; Yegorov YE
J Basic Clin Physiol Pharmacol; 2013; 24(1):1-26. PubMed ID: 23425625
[TBL] [Abstract][Full Text] [Related]
26. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.
Mozdzanowska K; Maiese K; Furchner M; Gerhard W
Virology; 1999 Feb; 254(1):138-46. PubMed ID: 9927581
[TBL] [Abstract][Full Text] [Related]
27. [The substances active against influenza virus. Possibilities and prospects of application].
Kwiatek M; Kocik J; Bartoszcze M
Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
[TBL] [Abstract][Full Text] [Related]
28. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
29. Broad-spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses.
Shin WJ; Lee KH; Park MH; Seong BL
Microbiol Immunol; 2010; 54(1):11-9. PubMed ID: 20055938
[TBL] [Abstract][Full Text] [Related]
30. Mathematical model of influenza A virus production in large-scale microcarrier culture.
Möhler L; Flockerzi D; Sann H; Reichl U
Biotechnol Bioeng; 2005 Apr; 90(1):46-58. PubMed ID: 15736163
[TBL] [Abstract][Full Text] [Related]
31. Architecture of ribonucleoprotein complexes in influenza A virus particles.
Noda T; Sagara H; Yen A; Takada A; Kida H; Cheng RH; Kawaoka Y
Nature; 2006 Jan; 439(7075):490-2. PubMed ID: 16437116
[TBL] [Abstract][Full Text] [Related]
32. Virus disease as a consequence of viral pathogenicity and the anti-viral immune response.
Rott R; Becht H
Behring Inst Mitt; 1992 Apr; (91):38-45. PubMed ID: 1326273
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.
Patel A; Tran K; Gray M; Li Y; Ao Z; Yao X; Kobasa D; Kobinger GP
Vaccine; 2009 May; 27(23):3083-9. PubMed ID: 19428922
[TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan.
Li WC; Shih SR; Huang YC; Chen GW; Chang SC; Hsiao MJ; Tsao KC; Lin TY
J Clin Virol; 2008 May; 42(1):45-51. PubMed ID: 18325832
[TBL] [Abstract][Full Text] [Related]
35. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
[TBL] [Abstract][Full Text] [Related]
36. Factors promoting pathogenicity of influenza virus.
Anderson PJ
Semin Respir Infect; 1991 Mar; 6(1):3-10. PubMed ID: 1887165
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
[TBL] [Abstract][Full Text] [Related]
38. Functional balance between haemagglutinin and neuraminidase in influenza virus infections.
Wagner R; Matrosovich M; Klenk HD
Rev Med Virol; 2002; 12(3):159-66. PubMed ID: 11987141
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of influenza C virus infection in children.
Matsuzaki Y; Katsushima N; Nagai Y; Shoji M; Itagaki T; Sakamoto M; Kitaoka S; Mizuta K; Nishimura H
J Infect Dis; 2006 May; 193(9):1229-35. PubMed ID: 16586359
[TBL] [Abstract][Full Text] [Related]
40. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein.
James CM; Abdad MY; Mansfield JP; Jacobsen HK; Vind AR; Stumbles PA; Bartlett EJ
Vaccine; 2007 Feb; 25(10):1856-67. PubMed ID: 17240000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
